VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $942 | -99.9% | 35,000 | -36.4% | 1.39% | -43.0% |
| Q2 2023 | $1,656,050 | +11.3% | 55,000 | +19.6% | 2.43% | +7.7% |
| Q1 2023 | $1,488,100 | +270.9% | 46,000 | +228.6% | 2.26% | +279.2% |
| Q4 2022 | $401,240 | -74.2% | 14,000 | -65.4% | 0.60% | -64.2% |
| Q1 2022 | $1,553,000 | +322.0% | 40,500 | +252.2% | 1.67% | +362.8% |
| Q4 2021 | $368,000 | +8.6% | 11,500 | 0.0% | 0.36% | +7.8% |
| Q3 2021 | $339,000 | -55.7% | 11,500 | -48.9% | 0.33% | -54.6% |
| Q2 2021 | $765,000 | +4.7% | 22,500 | 0.0% | 0.74% | -2.3% |
| Q1 2021 | $731,000 | -9.8% | 22,500 | 0.0% | 0.75% | -15.0% |
| Q4 2020 | $810,000 | -35.4% | 22,500 | -29.7% | 0.88% | -46.4% |
| Q3 2020 | $1,253,000 | +6.7% | 32,000 | 0.0% | 1.65% | -0.1% |
| Q2 2020 | $1,174,000 | +59.3% | 32,000 | 0.0% | 1.65% | +24.3% |
| Q1 2020 | $737,000 | – | 32,000 | – | 1.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |